AEROLET TOILET LIFT, MODEL AER-01
Device Facts
| Record ID | K031045 |
|---|---|
| Device Name | AEROLET TOILET LIFT, MODEL AER-01 |
| Applicant | Economic Holland B.V. |
| Product Code | INO · Physical Medicine |
| Decision Date | Jul 10, 2003 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 890.3110 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Indications for Use
Aerolet ToiletLift "K031045" was developed to assist in patient ability to access bathroom facilities due to medical conditions such as the following: Multiple Sclerosis Muscular Dystrophy Arthritis Inclusion Body Myositis Fredricks Ataxia Parkinsons Syndrome Post-Polio Syndrome Fragile elderly Rehabilitation Leg fractures Hip Replacement Knee Replacement Post-Operative Mobility
Device Story
Aerolet ToiletLift is an electric positioning chair designed to assist individuals with limited mobility in sitting and standing during toileting. The device consists of a motorized seat assembly that mounts over a standard toilet. The user leans back onto the seat and operates a control button (manual or optional wired remote) to lower or raise the seat at a controlled speed. The device allows for intermediate stops for perineal cleaning and features adjustable lift height limits. It is intended for use in home or institutional settings. A bariatric version supports up to 880 pounds using reinforced struts. The device aims to promote independence by reducing the need for caregiver assistance during toileting. It can be reconfigured for use as a shower lift.
Clinical Evidence
No clinical data provided; bench testing only.
Technological Characteristics
Electric positioning chair; steel construction with Rislan powder coating; Gortex seat materials; motorized lift mechanism (LINAK components); adjustable height; wired remote control option; bariatric configuration with reinforced struts; convertible to shower lift configuration.
Indications for Use
Indicated for patients with mobility impairments due to conditions including Multiple Sclerosis, Muscular Dystrophy, Arthritis, Inclusion Body Myositis, Fredricks Ataxia, Parkinsons Syndrome, Post-Polio Syndrome, fragility, or post-operative recovery (e.g., hip/knee replacement, leg fractures).
Regulatory Classification
Identification
An electric positioning chair is a device with a motorized positioning control that is intended for medical purposes and that can be adjusted to various positions. The device is used to provide stability for patients with athetosis (involuntary spasms) and to alter postural positions.
Special Controls
(1) Appropriate analysis and non-clinical testing must demonstrate that the safety controls are adequate to ensure safe use of the device and prevent user falls from the device in the event of a device failure; (2) Appropriate analysis and non-clinical testing must demonstrate the ability of the device to withstand the rated user weight load with an appropriate factor of safety; (3) Appropriate analysis and non-clinical testing must demonstrate the longevity of the device to withstand external forces applied to the device and provide the user with an expected service life of the device; (4) Appropriate analysis and non-clinical testing must demonstrate proper environments of use and storage of the device to maximize the longevity of the device; (5) Appropriate analysis and non-clinical testing (such as that outlined in the currently FDA-recognized editions of ANSI/AAMI/ES60601-1, “Medical Electrical Equipment—Part 1: General Requirements for Basic Safety and Essential Performance,” and ANSI/AAMI/IEC 60601-1-2, “Medical Electrical Equipment—Part 1-2: General Requirements for Basic Safety and Essential Performance—Collateral Standard: Electromagnetic Disturbances—Requirements and Tests”) must validate electromagnetic compatibility and electrical safety; (6) Appropriate analysis and non-clinical testing (such as that outlined in the currently FDA-recognized editions of ANSI/AAMI/ISO 10993-1, “Biological Evaluation of Medical Devices—Part 1: Evaluation and Testing Within a Risk Management Process,” ANSI/AAMI/ISO 10993-5, “Biological Evaluation of Medical Devices—Part 5: Tests for In Vitro Cytotoxicity,” and ANSI/AAMI/ISO 10993-10, “Biological Evaluation of Medical Devices—Part 10: Tests for Irritation and Skin Sensitization”) must validate that the skin-contacting components of the device are biocompatible; (7) Appropriate analysis and non-clinical testing (such as that outlined in the currently FDA-recognized editions of IEC 62304, “Medical Device Software—Software Life Cycle Processes”) must validate the software life cycle and that all processes, activities, and tasks are implemented and documented; (8) Appropriate analysis and non-clinical testing must validate that the device components are found to be non-flammable; (9) Appropriate analysis and non-clinical testing must validate that the battery in the device (if applicable) performs as intended over the anticipated service life of the device; and (10) Adequate patient labeling is provided to the user to document proper use and maintenance of the device to ensure safe use of the device by the patient in the intended use environment.